Annual report pursuant to Section 13 and 15(d)

Cash Equivalents and Marketable Securities

v3.22.0.1
Cash Equivalents and Marketable Securities
12 Months Ended
Dec. 31, 2021
Cash and Cash Equivalents [Abstract]  
Cash Equivalents and Marketable Securities

4. Cash Equivalents and Marketable Securities

Cash equivalents and marketable securities consisted of the following:

 

 

 

December 31, 2021

 

 

 

Amortized
Cost Basis

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair
Value

 

 

 

(in thousands)

 

Money market funds

 

$

29,451

 

 

$

-

 

 

$

-

 

 

$

29,451

 

Commercial paper

 

 

22,580

 

 

 

-

 

 

 

-

 

 

 

22,580

 

Corporate debt securities

 

 

75,012

 

 

 

-

 

 

 

(151

)

 

 

74,861

 

Asset-based securities

 

 

32,975

 

 

 

-

 

 

 

(18

)

 

 

32,957

 

U.S. government securities

 

 

47,504

 

 

 

-

 

 

 

(84

)

 

 

47,420

 

Supranational debt securities

 

 

21,361

 

 

 

-

 

 

 

(61

)

 

 

21,300

 

Total

 

 

228,883

 

 

 

-

 

 

 

(314

)

 

 

228,569

 

Less amounts classified as cash equivalents

 

 

(29,451

)

 

 

-

 

 

 

-

 

 

 

(29,451

)

Total marketable securities

 

$

199,432

 

 

$

-

 

 

$

(314

)

 

$

199,118

 

 

 

 

December 31, 2020

 

 

 

Amortized
Cost Basis

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair
Value

 

 

 

(in thousands)

 

Money market funds

 

$

204,632

 

 

$

-

 

 

$

-

 

 

$

204,632

 

Commercial paper

 

 

42,208

 

 

 

-

 

 

 

-

 

 

 

42,208

 

Corporate debt securities

 

 

25,669

 

 

 

48

 

 

 

(1

)

 

 

25,716

 

Asset-based securities

 

 

12,593

 

 

 

39

 

 

 

-

 

 

 

12,632

 

U.S. government securities

 

 

39,743

 

 

 

44

 

 

 

(2

)

 

 

39,785

 

Total

 

 

324,845

 

 

 

131

 

 

 

(3

)

 

 

324,973

 

Less amounts classified as cash equivalents

 

 

(204,632

)

 

 

-

 

 

 

-

 

 

 

(204,632

)

Total marketable securities

 

$

120,213

 

 

$

131

 

 

$

(3

)

 

$

120,341

 

 

As of December 31, 2021 and 2020, $68.8 million and zero, respectively, of marketable securities had maturities of more than one year and are classified as long-term assets.

There were $176.5 million and $14.7 million of investments in an unrealized loss position of $0.3 million and $3,000 as of December 31, 2021 and 2020, respectively. During the years ended December 31, 2021, 2020 and 2019, the Company did not record any other-than-temporary impairment charges on its available-for-sale securities. Based on the Company’s procedures under the expected credit loss model, including an assessment of unrealized gains on the portfolio after December 31, 2021, the Company concluded that the unrealized losses for its marketable securities were not attributable to credit and therefore an allowance for credit losses for these securities has not been recorded as of December 31, 2021. Also, based on the scheduled maturities of the investments, the Company was more likely than not to hold these investments for a period of time sufficient for a recovery of the Company’s cost basis.

The Company recognized no material gains or losses on its cash equivalents and current and non-current marketable securities as of December 31, 2021 and as a result, the Company did not reclassify any amounts out of accumulated other comprehensive income for the year then ended.